Legion logo
Sign in

Ultima Genomics

UG
Biotech / BiopharmaHealthTechUSFounded 2016Website
#441 by valuationHype57

Developer of genome-scale sequencing technology designed to offer analytical services to enterprises.

Founded by Gilad Almogy (CEO), Mark Pratt (Co-founder)

Blended valuation$1.8B$1.8B secondary
Valuation history
Weekly blended valuation with priced funding rounds marked on the timeline.
$1.9B
blended valuation
May 30, 2022$898.3MOct 5, 2026
All rounds
2 funding rounds, newest first.
RoundAnnouncedRaisedPost-money
RoundMay 31, 2022$600M$1B
RoundJan 1, 2021—$244.3M
Investors
9 investors across all rounds.
  • GA
    General Atlantic
  • AH
    Andreessen Horowitz
  • DC
    D1 Capital Partners
  • FF
    Founders Fund
  • KV
    Khosla Ventures
  • LV
    Lightspeed Venture Partners
  • PG
    Playground Global
  • AM
    aMoon
  • MN
    Marius Nacht
Secondary market activity
Recent buy and sell interest for Ultima Genomics shares on the secondary market.
KindImplied valuationPrice / shareDate
Ask$1.8B$24.80Sep 23, 2026
Ask$1.8B$25.00Sep 22, 2026
Ask$1.8B$24.78Sep 14, 2026
Sign in to view complete secondary-market activity

Invest in the private markets on Legion

Registered users see full trading activity, every investor, rankings, and live deals.

Get started

Data as of Oct 14, 2026. Valuations are estimates blended from primary and secondary-market signals — not investment advice.